Elelyso and Bronchitis - a phase IV clinical study of FDA data

Summary:

Bronchitis is reported as a side effect among people who take Elelyso (taliglucerase alfa), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Vancomycin, and have Infection.

The phase IV clinical study analyzes which people have Bronchitis when taking Elelyso. It is created by eHealthMe based on reports of 688 people who have side effects when taking Elelyso from the FDA, and is updated regularly.

What is Elelyso?

Elelyso has active ingredients of taliglucerase alfa. eHealthMe is studying from 688 Elelyso users. Check the latest studies of Elelyso.

What is Bronchitis?

Bronchitis (inflammation of the mucous membrane in the bronchial tubes) is found to be associated with 2,327 drugs and 2,440 conditions by eHealthMe. Check the latest studies of Bronchitis.

On Jul, 19, 2026

688 people reported to have side effects when taking Elelyso.
Among them, 15 people (2.18%) have Bronchitis.

Among these 15 people:

How long have people been on Elelyso when they have Bronchitis? *

What is the gender of people who have Bronchitis when taking Elelyso? *

female: 46.67 %
male: 53.33 %

What is the age of people who have Bronchitis when taking Elelyso? *

What are other drugs people take besides Elelyso? *

Vancomycin: 7 people, 46.67%
Spironolactone: 3 people, 20.00%
Repaglinide: 3 people, 20.00%
Furosemide: 3 people, 20.00%
Dutasteride: 3 people, 20.00%

What are other side effects people have besides Bronchitis? *

Fever: 14 people, 93.33%
Cough: 8 people, 53.33%
Hyperkalemia (damage to or disease of the kidney): 7 people, 46.67%
Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 46.67%
Heart Rate Irregular: 7 people, 46.67%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 46.67%
Heart Rate Decreased: 7 people, 46.67%
Faeces Discolored: 7 people, 46.67%
Endocarditis Bacterial (an inflammation of the inner layer of the heart by bacterial infection): 7 people, 46.67%
Weight Decreased: 7 people, 46.67%

What are the existing conditions these people have? *

Urinary Retention (the inability to completely or partially empty the bladder): 7 people, 46.67%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 7 people, 46.67%
Infection: 7 people, 46.67%

* Approximation only. Some reports may have incomplete information.

Do you take Elelyso and have Bronchitis?

- Check whether Bronchitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Elelyso:

Elelyso (688 reports)

Bronchitis treatments and more:

Bronchitis (118,921 reports)

Browse all side effects of Elelyso:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bronchitis:

Bronchitis (2,327 drugs)

Browse all the conditions that are associated with Bronchitis:

Bronchitis (2,440 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on taliglucerase alfa (the active ingredients of Elelyso) and Elelyso (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.